Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

2
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (2)

Searched Name

Health Policy Statement

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Bhavnani SP, Parakh K, Atreja A, Druz R, Graham GN, Hayek SS, Krumholz HM, Maddox TM, Majmudar MD, Rumsfeld JS, Shah BR. 2017 Roadmap for Innovation-ACC Health Policy Statement on Healthcare Transformation in the Era of Digital Health, Big Data, and Precision Health: A Report of the American College of Cardiology Task Force on Health Policy Statements and Systems of Care. J Am Coll Cardiol 2017;70:2696-718. [PMID: 29169478 DOI: 10.1016/j.jacc.2017.10.018] [Citation(s) in RCA: 70] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Abstract Collapse Key Words Health Policy Statement big data cardiovascular medicine digital health evidence-based medicine healthcare acceleration innovation organization and administration precision health Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
2	Sable CA, Ivy DD, Beekman RH, Clayton-Jeter HD, Jenkins KJ, Mahle WT, Morrow WR, Murphy MD, Nelson RM, Rosenthal GL, Stockbridge N, Wessel DL. 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil. J Am Coll Cardiol 2017;70:495-503. [PMID: 28669447 DOI: 10.1016/j.jacc.2017.04.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Abstract Collapse Key Words Health Policy Statement U.S. Food and Drug Administration drug development pediatric clinical trials sildenafil Collapse MESH Headings Cardiology/methods Cardiology/standards Child Child Advocacy Child Health/legislation & jurisprudence Dose-Response Relationship, Drug Drug Development/methods Drug Development/standards Drug and Narcotic Control/organization & administration Humans Hypertension, Pulmonary/drug therapy Hypertension, Pulmonary/mortality Mortality Off-Label Use/legislation & jurisprudence Outcome Assessment, Health Care/ethics Outcome Assessment, Health Care/statistics & numerical data Pediatrics/methods Pediatrics/standards Randomized Controlled Trials as Topic/ethics Randomized Controlled Trials as Topic/methods Randomized Controlled Trials as Topic/standards Sildenafil Citrate/administration & dosage Sildenafil Citrate/adverse effects Vasodilator Agents/administration & dosage Vasodilator Agents/adverse effects Collapse Grants FD999999 Intramural FDA HHS Collapse Affiliation(s) Collapse